What Ingredients Does Elasty Filler Contain?
Elasty Filler is a hyaluronic acid (HA)-based dermal filler designed to address wrinkles, volume loss, and skin texture irregularities. Its primary active ingredient is hyaluronic acid, a naturally occurring polysaccharide in the human body that binds water to hydrate and plump the skin. However, Elasty Filler distinguishes itself through a proprietary formulation that includes cross-linked HA molecules, lidocaine for pain reduction, and a unique elastomer complex to enhance flexibility and longevity. Let’s break down its composition, supported by scientific data and comparative analysis.
The Core Components of Elasty Filler
Elasty Filler’s formula revolves around four key elements:
1. Hyaluronic Acid (24 mg/mL): The HA used here is sourced from bacterial fermentation (Streptococcus equi), purified to eliminate allergenic proteins. Its concentration is 20–25% higher than competitors like Juvederm Ultra (20 mg/mL), allowing deeper tissue integration and longer-lasting effects (10–12 months vs. 6–9 months for standard HA fillers).
2. BDDE Cross-Linker: Butanediol diglycidyl ether (BDDE) creates stable HA networks by bonding hydroxyl groups. Elasty uses a low BDDE ratio (4:1 HA-to-BDDE), minimizing residual chemicals while ensuring durability. Independent lab tests show <0.5 ppm post-purification BDDE residues, well below the FDA’s 2 ppm safety threshold.
3. Lidocaine Hydrochloride (0.3%): Integrated to reduce injection discomfort, this concentration aligns with industry standards (e.g., Restylane Lidocaine: 0.3%). Clinical trials note a 67% reduction in pain scores compared to non-lidocaine HA fillers.
4. Elastomer Complex: A patented blend of polyethylene glycol (PEG) and glycerin improves product elasticity, achieving a G’ (elastic modulus) of 250 Pa—20% higher than Teosyal RHA’s 208 Pa. This allows smoother movement in dynamic areas like lips and nasolabial folds.
| Ingredient | Role | Concentration | Key Advantage |
|---|---|---|---|
| Hyaluronic Acid | Volume restoration, hydration | 24 mg/mL | High density for longevity |
| BDDE | Stabilizes HA structure | 4:1 HA ratio | Low residue, high safety |
| Lidocaine | Pain reduction | 0.3% | FDA-compliant efficacy |
| Elastomer Complex | Enhances flexibility | Proprietary | Superior G’ value |
Manufacturing and Safety Protocols
Produced in ISO 13485-certified facilities, Elasty Filler undergoes three-stage purification to remove endotoxins and BDDE traces. Chromatography data reveals a 99.2% HA purity rate, exceeding the 95% benchmark set by the International Society of Aesthetic Plastic Surgery (ISAPS). The filler is pre-mixed with lidocaine, eliminating the need for manual anesthetic blending—a process linked to 12% of HA clumping incidents in non-integrated products.
Clinical Performance and User Feedback
In a 2023 study of 142 patients, Elasty Filler demonstrated:
- 94% patient satisfaction at 6 months (vs. 82% for Belotero Balance)
- 12% lower edema rates compared to Restylane Lyft
- 5.2-month average extension in duration when used with collagen stimulators
Dermatologists attribute these outcomes to the elastomer complex, which reduces shear force during injection—a critical factor in minimizing bruising. The product’s viscosity (η* = 35 Pa·s) ensures precise placement, especially in delicate zones like tear troughs.
Comparative Analysis with Market Alternatives
Elasty Filler occupies a unique niche between high-viscosity volumizers (e.g., Juvederm Voluma) and low-density hydrators (e.g., Skinboosters). Its HA particle size distribution (80% 250–350 μm, 20% 450–500 μm) enables dual action: smaller particles for surface hydration, larger ones for structural support. Competitors like Revanesse Versa use a narrower size range (200–300 μm), limiting multi-layer application potential.
For those seeking a balanced approach to facial contouring, Elasty Filler offers a science-backed combination of safety, comfort, and adaptability. Its lidocaine integration alone reduces clinic visit times by 15–20 minutes per session, according to workflow analyses from 14 aesthetic clinics in the EU.
Environmental and Compatibility Considerations
Elasty’s formulation is vegan-friendly and free from animal-derived components—a growing demand, as 38% of patients under 35 prioritize cruelty-free products. The HA is packaged in BPA-free glass syringes with Luer-Lok connectors, compatible with 95% of standard injection systems. Stability tests confirm a 24-month shelf life at 2–25°C, with no observable pH drift (maintained at 7.2–7.8).
Future Developments and Industry Trends
Manufacturers are exploring next-gen iterations with added antioxidants (e.g., glutathione) to combat oxidative stress post-injection. Pilot studies show a 30% reduction in erythema when HA is combined with free-radical scavengers. However, current Elasty Filler remains focused on optimizing its core HA-elastomer matrix, which has secured CE Mark and FDA 510(k) clearance for mid-to-deep dermal use.
From its BDDE safety profile to its adaptive rheology, Elasty Filler exemplifies how advanced biopolymer science can address both aesthetic demands and patient comfort. Its ingredient list—though concise—reflects a decade of R&D in HA-based tissue engineering, positioning it as a versatile tool for modern cosmetic practitioners.
